| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Vinblastine | GDSC1000 | pan-cancer | AAC | -0.1 | 0.002 |
| mRNA | isonicotinohydroxamic acid | CTRPv2 | pan-cancer | AAC | 0.15 | 0.002 |
| mRNA | BEC | CTRPv2 | pan-cancer | AAC | 0.21 | 0.003 |
| mRNA | Mdivi-1 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |
| mRNA | PLX4720 | GDSC1000 | pan-cancer | AAC | -0.086 | 0.005 |
| mRNA | Pyrimethamine | GDSC1000 | pan-cancer | AAC | -0.14 | 0.006 |
| mRNA | BRD-A02303741 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.008 |
| mRNA | tacrolimus | CTRPv2 | pan-cancer | AAC | 0.096 | 0.008 |
| mRNA | ETP-46464 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.008 |
| mRNA | cediranib | CTRPv2 | pan-cancer | AAC | 0.14 | 0.009 |